Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
- 1 July 1999
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (7), 1623-1629
- https://doi.org/10.1161/01.atv.19.7.1623
Abstract
—Multiple data suggest that the renin-angiotensin system contributes to the pathogenesis of atherosclerosis. The atherogenic effect of the renin-angiotensin system can only in part be explained by the influence of its effector angiotensin II on blood pressure, smooth muscle cell (SMC) growth, or antifibrinolytic activity. Because chronic inflammation of the vessel wall is a hallmark of atherosclerosis, we hypothesized that angiotensin II may elicit inflammatory signals in vascular SMCs. Human vascular SMCs were stimulated with angiotensin. Inflammatory activation was assessed by determination of interleukin-6 (IL-6) release into the culture medium, detection of IL-6 mRNA by RT-PCR, and demonstration of activation of nuclear factor-κB in electrophoretic mobility shift assays. Angiotensin II concentration-dependently (1 nmol/L to 1 μmol/L) stimulated IL-6 production by SMCs via activation of the angiotensin II type 1 receptor (demonstrated by the inhibitory action of the receptor antagonist losartan). Angiotensin I increased IL-6 production by SMCs, too. This effect was inhibited by captopril and ramiprilat, suggesting conversion of angiotensin I to angiotensin II by angiotensin-converting enzyme in SMCs. Steady-state mRNA for IL-6 was augmented after stimulation with angiotensin II, suggesting regulation of angiotensin-induced IL-6 release at the pretranslational level. Moreover, the proinflammatory transcription factor nuclear factor-κB, which is necessary for transcription of most cytokine genes, was also activated by angiotensin II. Pyrrolidine dithiocarbamate suppressed angiotensin II–induced IL-6 release, a finding compatible with involvement of reactive oxygen species as second messengers in cytokine production mediated by angiotensin. The data demonstrate the ability of angiotensin to elicit an inflammatory response in human vascular SMCs by stimulation of cytokine production and activation of nuclear factor-κB. Inflammatory activation of the vessel wall by a dysregulated renin-angiotensin system may contribute to the pathogenesis of atherosclerosis.Keywords
This publication has 31 references indexed in Scilit:
- The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human AtherosclerosisPublished by Elsevier BV ,1997
- Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon-γPublished by Elsevier BV ,1996
- Activation of human peripheral monocytes by angiotensin IIFEBS Letters, 1994
- Function and Activation of NF-kappaB in the Immune SystemAnnual Review of Immunology, 1994
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionThe New England Journal of Medicine, 1991
- Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cellsJournal of Hypertension, 1991
- Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.Hypertension, 1990
- Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.JCI Insight, 1989
- Culture of quiescent arterial smooth muscle cells in a defined serum‐free mediumJournal of Cellular Physiology, 1983